Nature Reviews Gastroenterology & Hepatology Науки о здоровье
Choosing the right drug for the right patient with steatohepatitis
Аннотация
Nature Reviews Gastroenterology & Hepatology, Published online: 11 November 2026; doi:10.1038/s41575-026-01283-9 With resmetirom and semaglutide approved for non-cirrhotic steatohepatitis with fibrosis, new European guidance moves the question from whether to treat to whom to treat, and with what. The noninvasive, phenotype-driven framework of these guidelines will shape clinical practice, yet much of the recommendations rests on expert consensus rather than comparative or outcome data.